Journal of Neurochemistry · 1987 · 67 citations · 24 references
Life SciencesNeurosciencePharmacologyMolecular NeuroscienceNeurochemistryNeuropharmacologyDopaminergic PharmacologyDrug-induced NeurotoxicityMonoamine NeurochemistryNeurotoxic AgentsNeurotoxic MechanismsNeurotoxicity MechanismsBiological Activity FeaturesDopamine OxidationDopaminergic NeurodegenerationDopaminergic NeuronsNeurotoxic ActionNeurotoxicityNigrostriatal Dopamine PathwayNigrostriatal Dopamine System
Several analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) were synthesized and screened for their capacity to be oxidized by monoamine oxidase (MAO-A or MAO-B) and their capacity to produce nigrostriatal dopaminergic neurotoxicity in mice. All of the compounds were relatively weak substrates for MAO-A but many of the compounds were found to be good substrates for MAO-B. Only three of the compounds, in addition to MPTP itself, were found to be neurotoxic. These were 1-methyl-4-cyclohexyl-1,2,3,6-tetrahydropyridine, 1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3'-methoxyphenyl)-1,2,3,6-tetrahydropyridine. All three of these neurotoxic compounds were found to be substrates for MAO-B; in contrast no compound was found to be neurotoxic that was not oxidized by MAO-B. The capacity of the compounds studied to be oxidized by MAO-B appears to be an important aspect of the neurotoxic process.
24
Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis
J. William Langston, Philip L. Ballard, James W. Tetrud et al. · Science · 1983 · 4.9K citations
Richard S. Burns, Chuang C. Chiueh, Sanford P. Markey et al. · Proceedings of the National Academy of Sciences · 1983 · 2.1K citations · Full text
Medicine, Neuroscience, Pharmacology +17
Jonathan A. Javitch, Robert J. D’Amato, Stephen M. Strittmatter et al. · Proceedings of the National Academy of Sciences · 1985 · 1.3K citations · Full text
Medicine, Neuroscience, Pharmacology +17